Medibell designs and manufacturers imaging systems for ophthalmology applications, such as diagnosis of glaucoma, age-related macular degeneration, and damage caused by diabetic retinopathy.
One of the company’s leading products is the PNM60, a wide angle retinal camera that minimizes the percentage of patients that can not be photographed due to pupil size. PNM60 handles the smallest pupil size (2mm diameter or less) and provides a 60º field of view. The camera produces high-resolution images, expanding the diagnostic capabilities of conventional retinal cameras by creating piecemeal mosaic images.
Medibell was founded in 1999 and has received $7-8 million in financing to date, mostly from CMT Medical Technologies and it aims to break even by the end of 2007.
- Israeli Tech Scene Shows Glimmers of Recovery in Q1 2024 - April 30, 2024
- Gaming Investments Level Up: Early Signs of a Resurgence - April 24, 2024
- What could go wrong with Vinod Khosla’s techno-optimistic vision of the future - April 22, 2024